Skip to main content
. 2017 Jul 27;12:5359–5372. doi: 10.2147/IJN.S139039

Figure 2.

Figure 2

Schematic and design of the approach.

Notes: Marker-MNPs composed of nanobeads conjugated with an FAPα-sensitive substrate in tandem with a ligand-encoded reporter. These agents survey the vasculature for the sites where FAPα cleaves and releases the reporters into urine for analysis by ELISA.

Abbreviations: ELISA, enzyme-linked immunosorbent assay; FAPα, fibroblast activation protein α; MNPs, magnetic iron oxide nanoparticles.